Health-related Quality of Life: Validity, Reliability, and Responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in Patients with Rheumatoid Arthritis
Overview
Affiliations
Objective: To compare validity, reliability, and responsiveness of generic and disease specific health-related quality of life (HRQOL) instruments in rheumatoid arthritis (RA).
Methods: Two samples of patients completed the Medical Outcomes Study Short Form-36 Health Survey (SF-36), EuroQol (EQ)-5D, 15D, Rheumatoid Arthritis Quality of Life Scale (RAQoL), Health Assessment Questionnaire (HAQ), and visual analog scales (VAS) for pain, fatigue, and global RA. VALIDITY (convergent, discriminant, and known-groups) was evaluated in a cross-section of 200 patients. Reliability was evaluated by agreement (intraclass correlation coefficient; baseline to 2 weeks) and internal consistency (Cronbach's alpha); and responsiveness by the standardized response mean stratified on improvement, status quo, or deterioration in health status after 6 months in 150 patients followed longitudinally. Followup questionnaires (at 2 weeks and 6 months) included questions about changes in health status since baseline.
Results: The cross-sectional sample included 77% women, median age 57 years (range 19-87), disease duration 6 years (0-58), with Disease Activity Score 28-joint count (DAS28) of 3.10 (1.21-6.47). The longitudinal sample included 80% women, median age 60 years (22-82).
Validity: all instruments discriminated between low, moderate, and high DAS28. Reliability: RAQoL and HAQ displayed good repeatability (ICC > 0.95) and internal consistency (Cronbach's alpha > 0.90). Responsiveness: SF-36 bodily pain scale and VAS pain were responsive to both improvement and deterioration.
Conclusion: All instruments were valid measures for HRQOL in RA. The RAQoL and HAQ displayed the best reliability, while the SF-36 bodily pain scale and VAS pain were the most responsive. The choice of instrument should depend on the study objectives.
Kapetanakis S, Chaniotakis C, Tsioulas P, Gkantsinikoudis N Neurospine. 2025; 21(4):1210-1218.
PMID: 39765266 PMC: 11744524. DOI: 10.14245/ns.2448634.317.
Song Y, Chen Y, Wen L, He B, Ding Y, Liu M Front Public Health. 2025; 12:1478376.
PMID: 39744379 PMC: 11688321. DOI: 10.3389/fpubh.2024.1478376.
Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument.
Rohde G, Lehmann J, Pilz M, Rojas-Concha L, Holzner B, King M Qual Life Res. 2024; 34(2):429-443.
PMID: 39499479 PMC: 11865156. DOI: 10.1007/s11136-024-03824-8.
The Short Form 6 Dimensions (SF-6D): Development and Evolution.
Mukuria C, Rowen D, Mulhern B, McDool E, Kharroubi S, Bjorner J Appl Health Econ Health Policy. 2024; 23(1):19-33.
PMID: 39460886 PMC: 11729076. DOI: 10.1007/s40258-024-00919-8.
Strand V, Bender S, McCabe D Rheumatol Ther. 2024; 11(5):1291-1302.
PMID: 39120847 PMC: 11422532. DOI: 10.1007/s40744-024-00687-w.